Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 mars 2026 12h00 HE | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/16/2026.
05 mars 2026 08h27 HE | Source: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
03 mars 2026 08h23 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
02 mars 2026 12h00 HE | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/16/2026.
26 févr. 2026 12h00 HE | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
26 févr. 2026 08h34 HE | Source: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
24 févr. 2026 08h22 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
23 févr. 2026 12h00 HE | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
19 févr. 2026 12h00 HE | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Vistagen (VTGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 16, 2026.
19 févr. 2026 08h54 HE | Source: Bernstein Liebhard LLP

VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

Vistagen Shareholders Between April 1, 2024 and December 16, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit

Page suivante